No Picture
News

Gossamer Bio Announces 1-for-80 Reverse Stock Split

SAN DIEGO–(BUSINESS WIRE)—- $GOSS–Gossamer Bio, Inc. (Nasdaq: GOSS) (the “Company” or “Gossamer”), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated […]

No Picture
News

Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates

SAN DIEGO and SUZHOU, China, Sept. 09, 2026 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced the achievement of […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

L?kahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions

RUTHERFORD, N.J., & LA JOLLA, Calif.–(BUSINESS WIRE)–L?kahi Therapeutics™ launches three ai² divisions to potentially drive revenue, expand partnerships, develop talent, and accelerate innovation. Click here to view original post Click Here to Publish/Feature Your Company […]

No Picture
News

Moonwalk Biosciences Announces $70 Million Series B Financing to Advance Adipose-Targeted RNAi Therapies for Obesity and Cardiometabolic Diseases

SOUTH SAN FRANCISCO & SAN DIEGO–(BUSINESS WIRE)– #biotech–Moonwalk Biosciences Announces $70 Million Series B Financing to Advance Adipose-Targeted RNAi Therapies for Obesity and Cardiometabolic Diseases Click here to view original post Click Here to Publish/Feature […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Endeavor BioMedicines Presents New Quantitative Imaging Data from Analysis of Phase 2a Clinical Trial Evaluating Taladegib (ENV-101) in Patients with Idiopathic Pulmonary Fibrosis

SAN DIEGO–(BUSINESS WIRE)–Endeavor BioMedicines (“Endeavor”), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, today presented a quantitative imaging post hoc analysis from its Phase […]

News

Argonaut Manufacturing Services LS/Dx Business Announces Transition to Aluris Sciences, Backed by 1315 Capital

Same mission. Same team. Stronger platform for life sciences, diagnostics, and combination drug product customers. Carlsbad, CA — September 8, 2026 — Argonaut Manufacturing Services today announced that its life sciences, diagnostics, and combination drug […]

No Picture
News

Belite Bio Announces Submission of New Drug Application to the Ministry of Health, Labour, and Welfare in Japan under the Sakigake Designation System for Tinlarebant for the Treatment of Stargardt Disease Type 1

SAN DIEGO, Sept. 08, 2026 (GLOBE NEWSWIRE) — – Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026

CARLSBAD, Calif., Sept. 4, 2026 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced […]

News

Using Her Platform for the Planet

Growing up in Carlsbad, Elise Nishimura developed an early appreciation for the environment. Now a junior Environmental Systems major and UC San Diego softball player, she combines her academic and athletic passions through EcoAthletes, using […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Invivoscribe Begins Commercial Shipments of PrepQuant™ Systems, Enabling High-Sensitivity Sample Preparation for MRD Testing

SAN DIEGO–(BUSINESS WIRE)–Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced that commercial shipments of the PrepQuant™ System have begun in North America. First unveiled at the American Association […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

L?kahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business

RUTHERFORD, N.J., & LA JOLLA, Calif.–(BUSINESS WIRE)–L?kahi Therapeutics™ expands its ai² Futures Lab™ network through a collaboration with SDSU Fowler College of Business to identify therapeutic assets. Click here to view original post Click Here […]

No Picture
News

Rapalogix Health Establishes Research Laboratory at Princeton Innovation Center BioLabs to Advance Next-Generation Rapalogs

CARLSBAD, Calif.–(BUSINESS WIRE)–Rapalogix Health establishes a dedicated research laboratory at Princeton Innovation Center BioLabs to advance its next-generation rapalogs. Click here to view original post Click Here to Publish/Feature Your Company or Product News with […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Breakthrough Helps Expand Genetic Alphabet

Researchers at UC San Diego have demonstrated that one of biology’s most essential enzymes can accurately read and transcribe an expanded genetic alphabet containing eight DNA letters instead of the four used by all known […]

No Picture
News

Styx Biotechnologies Announces Strategic Agreement with ZoeNCure Therapeutics to Accelerate Next-Generation ADC Pipeline to Clinic

SAN DIEGO–(BUSINESS WIRE)–Styx Biotechnologies, Inc., a San Diego-based biotechnology company developing next-generation antibody-drug conjugates (ADCs) for solid tumors, today announced a strategic agreement with ZoeNCure Therapeutics Pvt. Ltd. to accelerate selected Styx ADC programs toward […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Strengthening America’s AI Ecosystem with the Launch of the NSF NAIRR Operations Center

Scientific discovery increasingly depends on AI resources, including large-scale computing, high-quality data and specialized tools. Without access to these resources, ambitious questions pursued by U.S. researchers may exceed the resources of an individual laboratory or […]


ADVERTISEMENT — Advertise With Biotech Networks